The framework reads distribution. Smart money appears to be selling into strength. Institutional holders may be rotating out. Price has moved down 10.8% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows negative risk-adjusted returns. Our composite framework grades it D, carrying a low risk profile. Technically it is holding around 1% above its long-term trend line with momentum reading bearish. Over the past year the shares are down 3%. Our forward projection puts the odds of a 10% gain over the next month near 20%. The street (1 analysts) rates it none, with a mean price target of $4.
Banco do Brasil S.A.
BDORY · OID · USD · Market cap $24.7B · 84,619 employees
Banco do Brasil S.A., together with its subsidiaries, provides banking products and services for individuals, companies, and public sectors in Brazil and internationally.
FAIL · Does not pass the screenAt the last full screen
2026-09-09
Screened 2026-09-09 · the tape above runs as of 15:00 UTC · two dates, stated on purpose · verdict and workings shown in full · never trimmed
This name holds its markup label.
Banco do Brasil S.A. holds its Markup at $4.32. The statistical read favours the sellers, held for 278 days.
| Phase | Markup |
| Quantitative state | The statistical read favours the sellers, held for 278 days |
| Price at the screen | $4.32 |
| Valuation | 10.29 trailing · 5.38 forward price to earnings |
| Values screen | FAIL · score 30.0 |
| Beta | 0.23 |
Five Screens, Shown in Full
Does not pass. Business activity
| Test | Figure | Limit | What it means | Status |
|---|---|---|---|---|
| Business activity | Excluded | Core business clean | Financial sector: banks | Fail |
| Debt load | 0.00% | Below 33% | Interest-bearing debt is just 0.0% of its assets, well under the one-third ceiling: it does not run on borrowed money. | Pass |
| Interest-bearing cash | 0.00% | Below 33% | Cash held in interest-bearing accounts and securities is 0.0% of assets, under the one-third limit. | Pass |
| Receivables | 0.00% | Below 49% | Money owed to the company is 0.0% of assets, under the 49% limit. | Pass |
| Revenue purity | 0.00% | Below 5% | Only 0.0% of revenue comes from non-compliant sources, under the 5% line. | Pass |
Five checks adapted from AAOIFI screening standards: business activity plus four balance-sheet ratios. All five must pass for ethical clearance. Every figure is arithmetic on public accounts, not judgement.
What the Numbers Say It Is WorthThe Fair Value Range
Our framework reads AVOID: it trades above our $3.98 fair value estimate, moderate competitive moat, 0.20% revenue growth.
Fair value range in USD, drawn from the 2026-09-09 screen. The gold marker is the market price at the same screen. The price runs 7.8% above the base estimate.
Reading the gap · Both our model and the Street see limited upside at this price.
Price History & ProjectionsWhere it has been, where the models see it going. History from market close data; projection points are our fair-value estimates and third-party analyst targets, dated to the 2026-09-09 screen.
Fair value and rating are our own model estimates; the Street's range reflects third-party analyst estimates. Analysis, not advice.
The Business, in Plain WordsState Lender Trips Ethical Alarm First
Picture a Brazilian farmer or civil servant wiring wages through the biggest state-owned bank in the country. The operation runs on public-sector ties that most private lenders avoid. That same link triggers our ethical screen and rules the name out before any valuation debate starts.
We pass for two clear reasons. The ethical flag sits at the top, and the numbers offer little comfort to offset it. Revenue is down 22 percent, return on equity sits at just 9 percent, and the thin 1 percent margin of safety above our fair value does nothing to change the call.
A 4.3 times forward multiple looks tempting on a regional bank until you remember earnings can swing hard with Brazilian policy and commodity cycles. One analyst target sits at the current price, so the market already prices in modest expectations. Analysis, not advice.
| Forward P/E | 5.4xexpensive even after accounting for its growth |
| Trailing P/E | 10.3xreasonably valued |
| EPS, trailing | 0.42 |
| EPS, forward | 0.80 |
| Revenue growth | +0.2%slow but positive growth |
| Profit margin | 21.8%healthy profit margins |
| Return on equity | 10.5%a modest return on shareholder capital |
| Dividend yield | 121.00% |
| Beta | 0.23barely tracks the market's swings |
| 52-week range | 3.47 - 5.47 |
| Moat | MODERATE |
| Market cap | $24.7B |
| Employees | 84,619 |
The risks · The things to watch: its business and earnings are exposed to Brazil and to currency swings.
Plain-English interpretation of our own screen data. Analysis, not advice.
Where & How to TradeBDORY trades on OID (the company is based in Brazil). As a listed security it is accessible through almost any international broker offering its home market. New to this, or investing from abroad? Our guide to accessing global markets covers brokers, currencies and the practical steps.
Every Entry, As Written
The framework reads distribution. Smart money appears to be selling into strength. Institutional holders may be rotating out. Price has moved up 4.6% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows modest positive risk-adjusted returns. Our composite framework grades it D, carrying a low risk profile. Technically it is holding around 1% above its long-term trend line with momentum reading bearish. Over the past year the shares are down 3%. Our forward projection puts the odds of a 10% gain over the next month near 20%. The street (1 analysts) rates it none, with a mean price target of $4.
The framework reads distribution. Smart money appears to be selling into strength. Institutional holders may be rotating out. Price has moved down 0.0% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows modest positive risk-adjusted returns. Our composite framework grades it D, carrying a low risk profile. Technically it is holding around 1% above its long-term trend line with momentum reading bearish. Over the past year the shares are down 3%. Our forward projection puts the odds of a 10% gain over the next month near 20%. The street (1 analysts) rates it none, with a mean price target of $4.
The framework reads distribution. Smart money appears to be selling into strength. Institutional holders may be rotating out. Price has moved down 0.0% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows modest positive risk-adjusted returns.
The framework reads distribution. Smart money appears to be selling into strength. Institutional holders may be rotating out. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows modest positive risk-adjusted returns.
Each entry above was written on its date, before the outcome. A journal you can prune is not a journal.
- Brazil pushes for focused rural debt relief as Senate passes broad bill Reuters · 17 Jun 2026
- Banco do Brasil wins 2026 Celent Model Bank of the Year Award Retail Banker International · 11 Jun 2026
- Brazil's government, federal district agree on BRB loan deal Reuters · 28 May 2026
- Banco do Brasil SA BB Brasil (BDORY) Q1 2026 Earnings Call Highlights: Strong Net Income Amid ... GuruFocus.com · 16 May 2026
- Brazilian payments network Elo selects banks for potential US IPO- report Electronic Payments · 12 May 2026
Headlines from third-party outlets, linked for reference: not our reporting, not advice.
Screened names in the same industry · explore each on its own page.
| Period | Price then | Price return | Divs per share | $1,000 became | Total return |
|---|---|---|---|---|---|
| 1 month | $4.44 | -15.5% | $0.03 | $851 | -14.9% |
| 2 months | $5.14 | -27.1% | $0.03 | $734 | -26.6% |
| 3 months | $4.62 | -18.8% | $0.03 | $818 | -18.2% |
| 6 months | $3.95 | -5.1% | $0.08 | $970 | -3.0% |
| 1 year | $3.85 | -2.6% | $0.08 | $995 | -0.5% |
| 2 years | $4.46 | -16.0% | $0.62 | $980 | -2.0% |
| 3 years | $3.91 | -4.1% | $1.01 | $1,218 | +21.8% |
| 5 years | $2.29 | +63.5% | $1.74 | $2,392 | +139.2% |
Historical returns from market close data. Past performance does not guarantee future results.
This entry now belongs to the ledger. Whatever BDORY does next, these words stay.
Thirteen thousand names carry this page. One desk keeps them honest.
Membership opens the full screen archive, the composites built from it, and the daily coverage that prices what the screen approves.
Join the deskScreening is research, not a fatwa and not financial advice. Figures are drawn from public accounts at the screen date shown. Always manage your risk.